Govt to expedite process of recognition of Biological E Corbevax by other countries

Published On 2022-04-30 06:26 GMT   |   Update On 2022-04-30 06:26 GMT

New Delhi: The government plans to expedite the process of recognition of COVID-19 vaccine Corbevax by other countries while its manufacturer Biological E pursues WHO's emergency use listing for the jab being administered in India among the 12-14 years age group.According to an internal document circulated to the members of the Empowered Group-5 on COVID-19 Vaccination, which will be...

Login or Register to read the full article

New Delhi: The government plans to expedite the process of recognition of COVID-19 vaccine Corbevax by other countries while its manufacturer Biological E pursues WHO's emergency use listing for the jab being administered in India among the 12-14 years age group.

According to an internal document circulated to the members of the Empowered Group-5 on COVID-19 Vaccination, which will be meeting soon, some authorities abroad such as in Hong Kong have begun demanding vaccination certificates for children and only accept m-RNA based vaccines for them.

"It is necessary to quickly initiate the process of recognition of the Corbevax vaccine and its certificate by other countries while Biological E continues to pursue WHO's EUL (emergency use listing ) for it," the document mentioned.

It highlighted that the recent development pertaining to the World Health Organizations' (WHO) suspension of Covaxin supply through UN procurement agencies further complicates the matter and is detrimental to the acceptance of Covaxin-based vaccination certificates for children by other countries.

The issues to be discussed by the Empowered Group-5 pertains to m-RNA based booster dose requirements by countries, suspension of supply of Covaxin by the WHO, acceptance of Corbevax and Covaxin based vaccination certificates for children and international travel by Indians vaccinated with Sputnik-V.

Read also: Biological E new recipient of mRNA technology through WHO technology transfer hub

Sources said the internal document circulated to members of the Empowered Group-5 comprehensively looks at all issues related to vaccines.

They said that selective highlighting of certain parts from the note could portray an incorrect picture as the document lists several issues in a factual manner for consideration of the empowered group and does not indicate the Ministry of External Affairs' position or comment on any issue under consideration.

Read also: Biological E gets CDSCO panel nod for Corbevax EUA for 5-11 years old

Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News